BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 40 hits Enz. Inhib. hit(s) with all data for entry = 9122   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Fibroblast growth factor receptor 4


(Homo sapiens (Human))
BDBM443226
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCC(CC3)N(C)C)ncn2)c1Cl
Show InChI InChI=1S/C30H36Cl2N8O4/c1-7-26(41)36-21-14-19(40-12-10-18(11-13-40)38(2)3)8-9-20(21)35-24-16-25(34-17-33-24)39(4)30(42)37-29-27(31)22(43-5)15-23(44-6)28(29)32/h7-9,14-18H,1,10-13H2,2-6H3,(H,36,41)(H,37,42)(H,33,34,35)
PDB

KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 1.10n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 4


(Homo sapiens (Human))
BDBM443223
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES CCN1CCC2(CN(C2)c2ccc(Nc3cc(ncn3)N(C)C(=O)Nc3c(Cl)c(OC)cc(OC)c3Cl)c(NC(=O)C=C)c2)CC1
Show InChI InChI=1S/C32H38Cl2N8O4/c1-6-27(43)38-22-14-20(42-17-32(18-42)10-12-41(7-2)13-11-32)8-9-21(22)37-25-16-26(36-19-35-25)40(3)31(44)39-30-28(33)23(45-4)15-24(46-5)29(30)34/h6,8-9,14-16,19H,1,7,10-13,17-18H2,2-5H3,(H,38,43)(H,39,44)(H,35,36,37)
PDB

KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 1.30n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 4


(Homo sapiens (Human))
BDBM443222
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCC4(C3)CCNCC4)ncn2)c1Cl
Show InChI InChI=1S/C31H36Cl2N8O4/c1-5-26(42)38-21-14-19(41-13-10-31(17-41)8-11-34-12-9-31)6-7-20(21)37-24-16-25(36-18-35-24)40(2)30(43)39-29-27(32)22(44-3)15-23(45-4)28(29)33/h5-7,14-16,18,34H,1,8-13,17H2,2-4H3,(H,38,42)(H,39,43)(H,35,36,37)
PDB

KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 4


(Homo sapiens (Human))
BDBM443225
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES CCN1CCC2(CCN(C2)c2ccc(Nc3cc(ncn3)N(C)C(=O)Nc3c(Cl)c(OC)cc(OC)c3Cl)c(NC(=O)C=C)c2)C1
Show InChI InChI=1S/C32H38Cl2N8O4/c1-6-27(43)38-22-14-20(42-13-11-32(18-42)10-12-41(7-2)17-32)8-9-21(22)37-25-16-26(36-19-35-25)40(3)31(44)39-30-28(33)23(45-4)15-24(46-5)29(30)34/h6,8-9,14-16,19H,1,7,10-13,17-18H2,2-5H3,(H,38,43)(H,39,44)(H,35,36,37)
PDB

KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.20n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 4


(Homo sapiens (Human))
BDBM443224
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES CCN1CCN(CC11CC1)c1ccc(Nc2cc(ncn2)N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)c(NC(=O)C=C)c1
Show InChI InChI=1S/C31H36Cl2N8O4/c1-6-26(42)37-21-14-19(40-12-13-41(7-2)31(17-40)10-11-31)8-9-20(21)36-24-16-25(35-18-34-24)39(3)30(43)38-29-27(32)22(44-4)15-23(45-5)28(29)33/h6,8-9,14-16,18H,1,7,10-13,17H2,2-5H3,(H,37,42)(H,38,43)(H,34,35,36)
PDB

KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.40n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 4


(Homo sapiens (Human))
BDBM443227
PNG
(N-(5-(4-Cyclopropylpiperazin-1-yl)-2-((6-(3-(2,6-d...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCN(CC3)C3CC3)ncn2)c1Cl
Show InChI InChI=1S/C30H34Cl2N8O4/c1-5-26(41)36-21-14-19(40-12-10-39(11-13-40)18-6-7-18)8-9-20(21)35-24-16-25(34-17-33-24)38(2)30(42)37-29-27(31)22(43-3)15-23(44-4)28(29)32/h5,8-9,14-18H,1,6-7,10-13H2,2-4H3,(H,36,41)(H,37,42)(H,33,34,35)
PDB

KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.5n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 4


(Homo sapiens (Human))
BDBM443228
PNG
(N-(5-(4-(Cyclopropyl(methyl)amino)piperidin-1-yl)-...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCC(CC3)N(C)C3CC3)ncn2)c1Cl
Show InChI InChI=1S/C32H38Cl2N8O4/c1-6-28(43)38-23-15-21(42-13-11-20(12-14-42)40(2)19-7-8-19)9-10-22(23)37-26-17-27(36-18-35-26)41(3)32(44)39-31-29(33)24(45-4)16-25(46-5)30(31)34/h6,9-10,15-20H,1,7-8,11-14H2,2-5H3,(H,38,43)(H,39,44)(H,35,36,37)
PDB

KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.80n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 4


(Homo sapiens (Human))
BDBM443221
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCNC4(CC4)C3)ncn2)c1Cl
Show InChI InChI=1S/C29H32Cl2N8O4/c1-5-24(40)36-19-12-17(39-11-10-34-29(15-39)8-9-29)6-7-18(19)35-22-14-23(33-16-32-22)38(2)28(41)37-27-25(30)20(42-3)13-21(43-4)26(27)31/h5-7,12-14,16,34H,1,8-11,15H2,2-4H3,(H,36,40)(H,37,41)(H,32,33,35)
PDB

KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 4.60n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 4


(Homo sapiens (Human))
BDBM443220
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CC4(C3)CCNCC4)ncn2)c1Cl
Show InChI InChI=1S/C30H34Cl2N8O4/c1-5-25(41)37-20-12-18(40-15-30(16-40)8-10-33-11-9-30)6-7-19(20)36-23-14-24(35-17-34-23)39(2)29(42)38-28-26(31)21(43-3)13-22(44-4)27(28)32/h5-7,12-14,17,33H,1,8-11,15-16H2,2-4H3,(H,37,41)(H,38,42)(H,34,35,36)
PDB

KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 4


(Homo sapiens (Human))
BDBM249396
PNG
(US10537571, Compound 108 | US10562888, Compound 10...)
Show SMILES CCN1CCN(CC1)c1ccc(Nc2cc(ncn2)N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)c(NC(=O)C=C)c1
Show InChI InChI=1S/C29H34Cl2N8O4/c1-6-25(40)35-20-14-18(39-12-10-38(7-2)11-13-39)8-9-19(20)34-23-16-24(33-17-32-23)37(3)29(41)36-28-26(30)21(42-4)15-22(43-5)27(28)31/h6,8-9,14-17H,1,7,10-13H2,2-5H3,(H,35,40)(H,36,41)(H,32,33,34)
PDB

KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
Purchase

MCE
PC cid
PC sid
UniChem
US Patent
n/an/a 14n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 1


(Homo sapiens (Human))
BDBM443221
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCNC4(CC4)C3)ncn2)c1Cl
Show InChI InChI=1S/C29H32Cl2N8O4/c1-5-24(40)36-19-12-17(39-11-10-34-29(15-39)8-9-29)6-7-18(19)35-22-14-23(33-16-32-22)38(2)28(41)37-27-25(30)20(42-3)13-21(43-4)26(27)31/h5-7,12-14,16,34H,1,8-11,15H2,2-4H3,(H,36,40)(H,37,41)(H,32,33,35)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 87n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 1


(Homo sapiens (Human))
BDBM443220
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CC4(C3)CCNCC4)ncn2)c1Cl
Show InChI InChI=1S/C30H34Cl2N8O4/c1-5-25(41)37-20-12-18(40-15-30(16-40)8-10-33-11-9-30)6-7-19(20)36-23-14-24(35-17-34-23)39(2)29(42)38-28-26(31)21(43-3)13-22(44-4)27(28)32/h5-7,12-14,17,33H,1,8-11,15-16H2,2-4H3,(H,37,41)(H,38,42)(H,34,35,36)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 160n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 2


(Homo sapiens (Human))
BDBM443223
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES CCN1CCC2(CN(C2)c2ccc(Nc3cc(ncn3)N(C)C(=O)Nc3c(Cl)c(OC)cc(OC)c3Cl)c(NC(=O)C=C)c2)CC1
Show InChI InChI=1S/C32H38Cl2N8O4/c1-6-27(43)38-22-14-20(42-17-32(18-42)10-12-41(7-2)13-11-32)8-9-21(22)37-25-16-26(36-19-35-25)40(3)31(44)39-30-28(33)23(45-4)15-24(46-5)29(30)34/h6,8-9,14-16,19H,1,7,10-13,17-18H2,2-5H3,(H,38,43)(H,39,44)(H,35,36,37)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 165n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 1


(Homo sapiens (Human))
BDBM443226
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCC(CC3)N(C)C)ncn2)c1Cl
Show InChI InChI=1S/C30H36Cl2N8O4/c1-7-26(41)36-21-14-19(40-12-10-18(11-13-40)38(2)3)8-9-20(21)35-24-16-25(34-17-33-24)39(4)30(42)37-29-27(31)22(43-5)15-23(44-6)28(29)32/h7-9,14-18H,1,10-13H2,2-6H3,(H,36,41)(H,37,42)(H,33,34,35)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 176n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 3


(Homo sapiens (Human))
BDBM443221
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCNC4(CC4)C3)ncn2)c1Cl
Show InChI InChI=1S/C29H32Cl2N8O4/c1-5-24(40)36-19-12-17(39-11-10-34-29(15-39)8-9-29)6-7-18(19)35-22-14-23(33-16-32-22)38(2)28(41)37-27-25(30)20(42-3)13-21(43-4)26(27)31/h5-7,12-14,16,34H,1,8-11,15H2,2-4H3,(H,36,40)(H,37,41)(H,32,33,35)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 179n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 2


(Homo sapiens (Human))
BDBM443221
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCNC4(CC4)C3)ncn2)c1Cl
Show InChI InChI=1S/C29H32Cl2N8O4/c1-5-24(40)36-19-12-17(39-11-10-34-29(15-39)8-9-29)6-7-18(19)35-22-14-23(33-16-32-22)38(2)28(41)37-27-25(30)20(42-3)13-21(43-4)26(27)31/h5-7,12-14,16,34H,1,8-11,15H2,2-4H3,(H,36,40)(H,37,41)(H,32,33,35)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 189n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 1


(Homo sapiens (Human))
BDBM249396
PNG
(US10537571, Compound 108 | US10562888, Compound 10...)
Show SMILES CCN1CCN(CC1)c1ccc(Nc2cc(ncn2)N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)c(NC(=O)C=C)c1
Show InChI InChI=1S/C29H34Cl2N8O4/c1-6-25(40)35-20-14-18(39-12-10-38(7-2)11-13-39)8-9-19(20)34-23-16-24(33-17-32-23)37(3)29(41)36-28-26(30)21(42-4)15-22(43-5)27(28)31/h6,8-9,14-17H,1,7,10-13H2,2-5H3,(H,35,40)(H,36,41)(H,32,33,34)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
Purchase

MCE
PC cid
PC sid
UniChem
US Patent
n/an/a 210n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 2


(Homo sapiens (Human))
BDBM443228
PNG
(N-(5-(4-(Cyclopropyl(methyl)amino)piperidin-1-yl)-...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCC(CC3)N(C)C3CC3)ncn2)c1Cl
Show InChI InChI=1S/C32H38Cl2N8O4/c1-6-28(43)38-23-15-21(42-13-11-20(12-14-42)40(2)19-7-8-19)9-10-22(23)37-26-17-27(36-18-35-26)41(3)32(44)39-31-29(33)24(45-4)16-25(46-5)30(31)34/h6,9-10,15-20H,1,7-8,11-14H2,2-5H3,(H,38,43)(H,39,44)(H,35,36,37)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 228n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 1


(Homo sapiens (Human))
BDBM443228
PNG
(N-(5-(4-(Cyclopropyl(methyl)amino)piperidin-1-yl)-...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCC(CC3)N(C)C3CC3)ncn2)c1Cl
Show InChI InChI=1S/C32H38Cl2N8O4/c1-6-28(43)38-23-15-21(42-13-11-20(12-14-42)40(2)19-7-8-19)9-10-22(23)37-26-17-27(36-18-35-26)41(3)32(44)39-31-29(33)24(45-4)16-25(46-5)30(31)34/h6,9-10,15-20H,1,7-8,11-14H2,2-5H3,(H,38,43)(H,39,44)(H,35,36,37)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 244n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 3


(Homo sapiens (Human))
BDBM443228
PNG
(N-(5-(4-(Cyclopropyl(methyl)amino)piperidin-1-yl)-...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCC(CC3)N(C)C3CC3)ncn2)c1Cl
Show InChI InChI=1S/C32H38Cl2N8O4/c1-6-28(43)38-23-15-21(42-13-11-20(12-14-42)40(2)19-7-8-19)9-10-22(23)37-26-17-27(36-18-35-26)41(3)32(44)39-31-29(33)24(45-4)16-25(46-5)30(31)34/h6,9-10,15-20H,1,7-8,11-14H2,2-5H3,(H,38,43)(H,39,44)(H,35,36,37)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 311n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 2


(Homo sapiens (Human))
BDBM443225
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES CCN1CCC2(CCN(C2)c2ccc(Nc3cc(ncn3)N(C)C(=O)Nc3c(Cl)c(OC)cc(OC)c3Cl)c(NC(=O)C=C)c2)C1
Show InChI InChI=1S/C32H38Cl2N8O4/c1-6-27(43)38-22-14-20(42-13-11-32(18-42)10-12-41(7-2)17-32)8-9-21(22)37-25-16-26(36-19-35-25)40(3)31(44)39-30-28(33)23(45-4)15-24(46-5)29(30)34/h6,8-9,14-16,19H,1,7,10-13,17-18H2,2-5H3,(H,38,43)(H,39,44)(H,35,36,37)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 368n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 1


(Homo sapiens (Human))
BDBM443223
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES CCN1CCC2(CN(C2)c2ccc(Nc3cc(ncn3)N(C)C(=O)Nc3c(Cl)c(OC)cc(OC)c3Cl)c(NC(=O)C=C)c2)CC1
Show InChI InChI=1S/C32H38Cl2N8O4/c1-6-27(43)38-22-14-20(42-17-32(18-42)10-12-41(7-2)13-11-32)8-9-21(22)37-25-16-26(36-19-35-25)40(3)31(44)39-30-28(33)23(45-4)15-24(46-5)29(30)34/h6,8-9,14-16,19H,1,7,10-13,17-18H2,2-5H3,(H,38,43)(H,39,44)(H,35,36,37)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 382n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 2


(Homo sapiens (Human))
BDBM443226
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCC(CC3)N(C)C)ncn2)c1Cl
Show InChI InChI=1S/C30H36Cl2N8O4/c1-7-26(41)36-21-14-19(40-12-10-18(11-13-40)38(2)3)8-9-20(21)35-24-16-25(34-17-33-24)39(4)30(42)37-29-27(31)22(43-5)15-23(44-6)28(29)32/h7-9,14-18H,1,10-13H2,2-6H3,(H,36,41)(H,37,42)(H,33,34,35)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 405n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 3


(Homo sapiens (Human))
BDBM443223
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES CCN1CCC2(CN(C2)c2ccc(Nc3cc(ncn3)N(C)C(=O)Nc3c(Cl)c(OC)cc(OC)c3Cl)c(NC(=O)C=C)c2)CC1
Show InChI InChI=1S/C32H38Cl2N8O4/c1-6-27(43)38-22-14-20(42-17-32(18-42)10-12-41(7-2)13-11-32)8-9-21(22)37-25-16-26(36-19-35-25)40(3)31(44)39-30-28(33)23(45-4)15-24(46-5)29(30)34/h6,8-9,14-16,19H,1,7,10-13,17-18H2,2-5H3,(H,38,43)(H,39,44)(H,35,36,37)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 439n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 1


(Homo sapiens (Human))
BDBM443222
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCC4(C3)CCNCC4)ncn2)c1Cl
Show InChI InChI=1S/C31H36Cl2N8O4/c1-5-26(42)38-21-14-19(41-13-10-31(17-41)8-11-34-12-9-31)6-7-20(21)37-24-16-25(36-18-35-24)40(2)30(43)39-29-27(32)22(44-3)15-23(45-4)28(29)33/h5-7,14-16,18,34H,1,8-13,17H2,2-4H3,(H,38,42)(H,39,43)(H,35,36,37)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 465n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 2


(Homo sapiens (Human))
BDBM443224
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES CCN1CCN(CC11CC1)c1ccc(Nc2cc(ncn2)N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)c(NC(=O)C=C)c1
Show InChI InChI=1S/C31H36Cl2N8O4/c1-6-26(42)37-21-14-19(40-12-13-41(7-2)31(17-40)10-11-31)8-9-20(21)36-24-16-25(35-18-34-24)39(3)30(43)38-29-27(32)22(44-4)15-23(45-5)28(29)33/h6,8-9,14-16,18H,1,7,10-13,17H2,2-5H3,(H,37,42)(H,38,43)(H,34,35,36)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 533n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 1


(Homo sapiens (Human))
BDBM443225
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES CCN1CCC2(CCN(C2)c2ccc(Nc3cc(ncn3)N(C)C(=O)Nc3c(Cl)c(OC)cc(OC)c3Cl)c(NC(=O)C=C)c2)C1
Show InChI InChI=1S/C32H38Cl2N8O4/c1-6-27(43)38-22-14-20(42-13-11-32(18-42)10-12-41(7-2)17-32)8-9-21(22)37-25-16-26(36-19-35-25)40(3)31(44)39-30-28(33)23(45-4)15-24(46-5)29(30)34/h6,8-9,14-16,19H,1,7,10-13,17-18H2,2-5H3,(H,38,43)(H,39,44)(H,35,36,37)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 544n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 3


(Homo sapiens (Human))
BDBM443220
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CC4(C3)CCNCC4)ncn2)c1Cl
Show InChI InChI=1S/C30H34Cl2N8O4/c1-5-25(41)37-20-12-18(40-15-30(16-40)8-10-33-11-9-30)6-7-19(20)36-23-14-24(35-17-34-23)39(2)29(42)38-28-26(31)21(43-3)13-22(44-4)27(28)32/h5-7,12-14,17,33H,1,8-11,15-16H2,2-4H3,(H,37,41)(H,38,42)(H,34,35,36)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 557n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 3


(Homo sapiens (Human))
BDBM249396
PNG
(US10537571, Compound 108 | US10562888, Compound 10...)
Show SMILES CCN1CCN(CC1)c1ccc(Nc2cc(ncn2)N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)c(NC(=O)C=C)c1
Show InChI InChI=1S/C29H34Cl2N8O4/c1-6-25(40)35-20-14-18(39-12-10-38(7-2)11-13-39)8-9-19(20)34-23-16-24(33-17-32-23)37(3)29(41)36-28-26(30)21(42-4)15-22(43-5)27(28)31/h6,8-9,14-17H,1,7,10-13H2,2-5H3,(H,35,40)(H,36,41)(H,32,33,34)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
Purchase

MCE
PC cid
PC sid
UniChem
US Patent
n/an/a 575n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 2


(Homo sapiens (Human))
BDBM249396
PNG
(US10537571, Compound 108 | US10562888, Compound 10...)
Show SMILES CCN1CCN(CC1)c1ccc(Nc2cc(ncn2)N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)c(NC(=O)C=C)c1
Show InChI InChI=1S/C29H34Cl2N8O4/c1-6-25(40)35-20-14-18(39-12-10-38(7-2)11-13-39)8-9-19(20)34-23-16-24(33-17-32-23)37(3)29(41)36-28-26(30)21(42-4)15-22(43-5)27(28)31/h6,8-9,14-17H,1,7,10-13H2,2-5H3,(H,35,40)(H,36,41)(H,32,33,34)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
Purchase

MCE
PC cid
PC sid
UniChem
US Patent
n/an/a 579n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 1


(Homo sapiens (Human))
BDBM443227
PNG
(N-(5-(4-Cyclopropylpiperazin-1-yl)-2-((6-(3-(2,6-d...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCN(CC3)C3CC3)ncn2)c1Cl
Show InChI InChI=1S/C30H34Cl2N8O4/c1-5-26(41)36-21-14-19(40-12-10-39(11-13-40)18-6-7-18)8-9-20(21)35-24-16-25(34-17-33-24)38(2)30(42)37-29-27(31)22(43-3)15-23(44-4)28(29)32/h5,8-9,14-18H,1,6-7,10-13H2,2-4H3,(H,36,41)(H,37,42)(H,33,34,35)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 618n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 1


(Homo sapiens (Human))
BDBM443224
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES CCN1CCN(CC11CC1)c1ccc(Nc2cc(ncn2)N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)c(NC(=O)C=C)c1
Show InChI InChI=1S/C31H36Cl2N8O4/c1-6-26(42)37-21-14-19(40-12-13-41(7-2)31(17-40)10-11-31)8-9-20(21)36-24-16-25(35-18-34-24)39(3)30(43)38-29-27(32)22(44-4)15-23(45-5)28(29)33/h6,8-9,14-16,18H,1,7,10-13,17H2,2-5H3,(H,37,42)(H,38,43)(H,34,35,36)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 624n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 2


(Homo sapiens (Human))
BDBM443227
PNG
(N-(5-(4-Cyclopropylpiperazin-1-yl)-2-((6-(3-(2,6-d...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCN(CC3)C3CC3)ncn2)c1Cl
Show InChI InChI=1S/C30H34Cl2N8O4/c1-5-26(41)36-21-14-19(40-12-10-39(11-13-40)18-6-7-18)8-9-20(21)35-24-16-25(34-17-33-24)38(2)30(42)37-29-27(31)22(43-3)15-23(44-4)28(29)32/h5,8-9,14-18H,1,6-7,10-13H2,2-4H3,(H,36,41)(H,37,42)(H,33,34,35)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 644n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 3


(Homo sapiens (Human))
BDBM443222
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCC4(C3)CCNCC4)ncn2)c1Cl
Show InChI InChI=1S/C31H36Cl2N8O4/c1-5-26(42)38-21-14-19(41-13-10-31(17-41)8-11-34-12-9-31)6-7-20(21)37-24-16-25(36-18-35-24)40(2)30(43)39-29-27(32)22(44-3)15-23(45-4)28(29)33/h5-7,14-16,18,34H,1,8-13,17H2,2-4H3,(H,38,42)(H,39,43)(H,35,36,37)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 715n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 3


(Homo sapiens (Human))
BDBM443226
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCC(CC3)N(C)C)ncn2)c1Cl
Show InChI InChI=1S/C30H36Cl2N8O4/c1-7-26(41)36-21-14-19(40-12-10-18(11-13-40)38(2)3)8-9-20(21)35-24-16-25(34-17-33-24)39(4)30(42)37-29-27(31)22(43-5)15-23(44-6)28(29)32/h7-9,14-18H,1,10-13H2,2-6H3,(H,36,41)(H,37,42)(H,33,34,35)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 729n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 3


(Homo sapiens (Human))
BDBM443225
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES CCN1CCC2(CCN(C2)c2ccc(Nc3cc(ncn3)N(C)C(=O)Nc3c(Cl)c(OC)cc(OC)c3Cl)c(NC(=O)C=C)c2)C1
Show InChI InChI=1S/C32H38Cl2N8O4/c1-6-27(43)38-22-14-20(42-13-11-32(18-42)10-12-41(7-2)17-32)8-9-21(22)37-25-16-26(36-19-35-25)40(3)31(44)39-30-28(33)23(45-4)15-24(46-5)29(30)34/h6,8-9,14-16,19H,1,7,10-13,17-18H2,2-5H3,(H,38,43)(H,39,44)(H,35,36,37)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 731n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 2


(Homo sapiens (Human))
BDBM443220
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CC4(C3)CCNCC4)ncn2)c1Cl
Show InChI InChI=1S/C30H34Cl2N8O4/c1-5-25(41)37-20-12-18(40-15-30(16-40)8-10-33-11-9-30)6-7-19(20)36-23-14-24(35-17-34-23)39(2)29(42)38-28-26(31)21(43-3)13-22(44-4)27(28)32/h5-7,12-14,17,33H,1,8-11,15-16H2,2-4H3,(H,37,41)(H,38,42)(H,34,35,36)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 777n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 3


(Homo sapiens (Human))
BDBM443227
PNG
(N-(5-(4-Cyclopropylpiperazin-1-yl)-2-((6-(3-(2,6-d...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCN(CC3)C3CC3)ncn2)c1Cl
Show InChI InChI=1S/C30H34Cl2N8O4/c1-5-26(41)36-21-14-19(40-12-10-39(11-13-40)18-6-7-18)8-9-20(21)35-24-16-25(34-17-33-24)38(2)30(42)37-29-27(31)22(43-3)15-23(44-4)28(29)32/h5,8-9,14-18H,1,6-7,10-13H2,2-4H3,(H,36,41)(H,37,42)(H,33,34,35)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 880n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 3


(Homo sapiens (Human))
BDBM443224
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES CCN1CCN(CC11CC1)c1ccc(Nc2cc(ncn2)N(C)C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)c(NC(=O)C=C)c1
Show InChI InChI=1S/C31H36Cl2N8O4/c1-6-26(42)37-21-14-19(40-12-13-41(7-2)31(17-40)10-11-31)8-9-20(21)36-24-16-25(35-18-34-24)39(3)30(43)38-29-27(32)22(44-4)15-23(45-5)28(29)33/h6,8-9,14-16,18H,1,7,10-13,17H2,2-5H3,(H,37,42)(H,38,43)(H,34,35,36)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 989n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 2


(Homo sapiens (Human))
BDBM443222
PNG
(N-(2-((6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-m...)
Show SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccc(cc3NC(=O)C=C)N3CCC4(C3)CCNCC4)ncn2)c1Cl
Show InChI InChI=1S/C31H36Cl2N8O4/c1-5-26(42)38-21-14-19(41-13-10-31(17-41)8-11-34-12-9-31)6-7-20(21)37-24-16-25(36-18-35-24)40(2)30(43)39-29-27(32)22(44-3)15-23(45-4)28(29)33/h5-7,14-16,18,34H,1,8-13,17H2,2-4H3,(H,38,42)(H,39,43)(H,35,36,37)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.43E+3n/an/an/an/an/an/a



Zhejiang Hisun Pharmaceutical Co., Ltd.

US Patent


Assay Description
The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then gradi...


US Patent US10654836 (2020)


BindingDB Entry DOI: 10.7270/Q25M68RT
More data for this
Ligand-Target Pair